This DoD Peer Reviewed Medical Clinical Trial Award is designed to support the swift execution of clinical trials aiming for substantial impact on diseases or conditions specified in the FY17 PRMRP Topic Areas. This grant from the Department of Defense facilitates the evaluation of promising new products, pharmacologic agents, medical devices, clinical guidance, and emerging technologies. Projects can range from small, proof-of-concept studies to large-scale efficacy trials. A core requirement is that all studies must address the healthcare needs of military Service members, Veterans, or beneficiaries, although direct use of these populations is not mandatory for the trial.
Opportunity ID: 294147
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-PRMRP-CTA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 9 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 27, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 26, 2017 |
| Current Closing Date for Applications: | Oct 26, 2017 |
| Archive Date: | Nov 25, 2017 |
| Estimated Total Program Funding: | $54,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of the military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 294147 Full Announcement-FY17 PRMRP CTA PA -> W81XWH-17-PRMRP-CTA.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00232810 | May 27, 2017 | Oct 26, 2017 | View |
Package 1
Mandatory forms
294147 RR_SF424_2_0-2.0.pdf
294147 RR_Budget_1_4-1.4.pdf
294147 RR_KeyPersonExpanded_2_0-2.0.pdf
294147 PerformanceSite_2_0-2.0.pdf
294147 AttachmentForm_1_2-1.2.pdf
Optional forms
294147 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
